The SME initial public offering (IPO) of Gujarat-headquartered sulfur-based inorganic chemicals, industrial sulfuric acid derivatives, and specialty chemical formulations manufacturer Shanti Inorganic…
The SME initial public offering (IPO) of Gujarat-headquartered sulfur-based inorganic chemicals, industrial sulfuric acid derivatives, and specialty chemical formulations manufacturer Shanti Inorganics Limited concluded its multi-day book-building bidding window across national bourses today, Wednesday, September 2, 2026.
Following an aggressive ramp-up across Day 1 (1.26x) and Day 2 (3.89x), the third and final trading session witnessed a massive influx of institutional, corporate treasury, and retail capital. By the close of bidding at 5:00 PM IST across the NSE SME platform, central exchange matching registries compiled valid electronic application tokens for 53,83,88,800 equity shares against a net public offer pool of 37,87,200 equity shares (excluding anchor allocations and the market maker reservation block of 2,84,800 shares).
This propelled the final cumulative subscription baseline to an extraordinary 142.16 times (14,216% coverage).
High-net-worth wealth accounts (HNIs), Qualified Institutional Buyers (QIBs), and retail individual investors all closed well above the century mark, taking their respective quotas to 195.53 times, 130.97 times, and 125.70 times.
Priced within an official price band parameter of ₹79.00 to ₹83.00 per share with an aggregate capital issue size of ₹47.24 crore, the public offering mobilized an aggregate primary capital demand value of ₹4,468.63 crore (~₹4.47 Thousand Crore) clearing through central registries (calculated at the upper price band cap of ₹83 per share).
With public bidding officially locked, market attention shifts directly to final allotment probabilities, unlisted grey market trends, chemical plant capex execution milestones, and the upcoming stock exchange debut scheduled for Monday, September 7, 2026.
Here is an extended, plain-English breakdown covering final subscription metrics, unlisted grey market trends, business operations across sulfur chemistry and industrial inorganic compounds, financial performance, capex deployment plans, valuation parameters, and the step-by-step allotment guide.
1. Final Subscription Data Breakdown
By 5:00 PM on the final day, central exchange processing registries compiled total valid application orders worth ₹4,468.63 crore (calculated at the upper price band cap of ₹83 per share), covering 14,216% of the net public offer.
The table below summarizes the closing performance across all investor categories:
+-----------------------------------------------------------------------------------+ | SHANTI INORGANICS LIMITED: FINAL SUBSCRIPTION DATA | +-------------------+-----------------+------------------+------------------+-------+ | Category | Shares Offered | Shares Bid For | Final Sub (x) | Value | +-------------------+-----------------+------------------+------------------+-------+ | QIB (Institutions)| 10,81,600 | 14,16,54,400 | 130.97x | ₹1,175.73Cr | NII / HNI (Wealth)| 8,11,200 | 15,86,16,000 | 195.53x | ₹1,316.51Cr | Retail (RII) | 18,94,400 | 23,81,18,400 | 125.70x | ₹1,976.38Cr | Market Maker | 2,84,800 | — | — | — | +-------------------+-----------------+------------------+------------------+-------+ | Total Net Offer | 37,87,200 | 53,83,88,800 | 142.16x | ₹4,468.63Cr +-------------------+-----------------+------------------+------------------+-------+
(Source: NSE SME Consolidated Bidding Platform Data)
Analyzing the Final Category Inflows:
- Non-Institutional Investors (NII / HNI - 195.53x): High-net-worth wealth accounts, corporate treasuries, and family offices posted the highest category oversubscription rate, surging from 20.69 lakh shares (3.93x) on Day 2 to 15,86,16,000 shares worth ₹1,316.51 crore against 8.11 lakh shares offered, closing at 195.53 times. Both small-HNI (sNII) and big-HNI (bNII) brackets recorded massive multi-lot participation.
- Qualified Institutional Buyers (QIB - 130.97x): Institutional desks deployed heavy block orders during the final afternoon session, rocketing from 17.58 lakh shares (1.63x) on Day 2 to 14,16,54,400 shares worth ₹1,175.73 crore against 10.82 lakh shares offered in their net allocation slice, driving institutional coverage to 130.97 times.
- Retail Individual Investors (RII - 125.70x): Everyday retail accounts expanded their bids more than twofold from Day 2 to reach 23,81,18,400 shares (74,412 application lots) worth ₹1,976.38 crore against 18.94 lakh shares reserved for them, pushing retail coverage to 125.70 times. Under the issue rules for this SME offer, retail applicants faced a minimum lot requirement of 2 lots (3,200 shares), requiring an upfront layout of ₹2,65,600 at ₹83 per share.
- Anchor Investor Allocation: Prior to the public open, Shanti Inorganics raised ₹13.44 crore through its institutional anchor placement on Friday, August 28, 2026, allocating 16,19,200 equity shares at ₹83 per share to institutional anchor funds.
- Market Maker Block: A dedicated block of 2,84,800 shares (~₹2.36 crore) is reserved for the designated market maker (Rikhav Securities Limited) to provide secondary market quote liquidity support post-listing.
2. Unlisted Grey Market Premium (GMP) & Expected Listing Gains
With final bidding figures locking in at an explosive 142.16x overall coverage, sentiment in the unlisted grey market corridors has strengthened:
- Fixed Upper Price Cap Anchor: ₹83.00 per share
- Current Grey Market Premium (GMP): Tracking around +₹32.00 to +₹38.00 per share (~38.6% to 45.8% over issue price)
- Estimated Listing Price Range: Expected debut counter level of ₹115.00 to ₹121.00 per share
- Projected Listing Gain Margin: Indicating an immediate estimated listing upside of ~38.55% to 45.78%
- Retail Minimum Application Lot Size: 2 Lots / 3,200 Shares (Minimum Investment: ₹2,65,600)
What Is Driving Grey Market Optimism?
- Established Sulfur-Chemistry Moat: Manufacturing essential sulfur-based chemical compounds, sulfur dioxide, and sulfuric acid derivatives supplied to agrochemical, pharmaceutical, textile, and water treatment manufacturers.
- Expanding Profitability (₹10.22 Cr PAT in FY26): Revenue expanded to ₹71.22 crore in FY26 with PAT crossing ₹10.22 crore, delivering a 25.16% EBITDA margin and healthy return on net worth.
(Note: Grey market premiums represent informal, off-exchange quotes traded among dealers. They fluctuate based on daily market mood and should not be treated as a guaranteed listing price.)
3. Business Overview: What Does Shanti Inorganics Do?
Incorporated in 2010 and headquartered in Gujarat, Shanti Inorganics Limited is an integrated manufacturer and trader of sulfur-based inorganic chemicals and industrial chemical intermediate compounds.
The company's product portfolio includes:
- Sulfur Dioxide & Liquid SO₂: High-purity industrial sulfur dioxide used in sugar bleaching, chemical synthesis, agrochemicals, and pharmaceutical intermediates.
- Sulfuric Acid Derivatives & Specialty Sulfites: Sodium bisulfite, sodium metabisulfite, and related sulfur salts catering to water treatment, mining, paper, and textile processing.
- Trading of Chemical Solvents & Bulk Inorganics: Sourcing and supplying allied industrial chemical raw materials to institutional end-users across India and international markets.
+-----------------------------------------------------------------------------------+ | SHANTI INORGANICS BUSINESS AT A GLANCE | +-----------------------------------+-----------------------------------------------+ | Core Focus Area | Sulfur-Based Inorganic Chemicals & Derivatives| +-----------------------------------+-----------------------------------------------+ | Product Portfolio Depth | Sulfur Dioxide (Liquid SO₂), Sulfites, Salts | +-----------------------------------+-----------------------------------------------+ | Key End-User Sectors | Agrochemicals, Pharma, Sugar, Water Treatment | +-----------------------------------+-----------------------------------------------+ | Operating Infrastructure | Advanced Chemical Manufacturing Plant (GJ) | +-----------------------------------+-----------------------------------------------+ | Customer Reach | 64+ Domestic & International Clients (FY26) | +-----------------------------------+-----------------------------------------------+ | Lead Manager (BRLM) | Vivro Financial Services Private Limited | +-----------------------------------+-----------------------------------------------+ | Registrar to the Issue | KFin Technologies Limited | +-----------------------------------+-----------------------------------------------+
Core Competitive Moats:
1. Niche Sulfur Chemistry Focus & Hazardous Handling Approvals
Manufacturing and transporting liquefied gases like SO₂ requires specialized high-pressure storage infrastructure, dedicated tanker logistics, and stringent environmental Pollution Control Board (PCB) clearances that create substantial entry barriers.
2. Diversified Downstream Industrial Demand
The company's chemicals serve non-cyclical, essential manufacturing sectors—including pharmaceuticals, agricultural crop care, wastewater remediation, and food preservation.
3. 100% Fresh Issue Primary Structure
No promoter dilution of funds; 100% of proceeds move into capacity expansion and working capital to support growing order volumes.
4. Detailed Financial Performance (FY24 to FY26)
An audit of the company's restated financial statements shows consistent top-line growth and expanding operational profitability over the last three fiscal years.
+-----------------------------------------------------------------------------------+ | SHANTI INORGANICS: 3-YEAR FINANCIAL PERFORMANCE | +-------------------------------+-------------------+-------------------+-----------+ | Financial Metric (₹ in Cr) | FY24 | FY25 | FY26 | +-------------------------------+-------------------+-------------------+-----------+ | Revenue from Operations | 44.87 | 57.11 | 71.22 | | Total Income | 45.06 | 58.46 | 72.93 | | Operating EBITDA | 8.12 | 12.80 | 17.92 | | EBITDA Margin (%) | 18.09% | 22.41% | 25.16% | | Net Profit After Tax (PAT) | 5.12 | 8.26 | 10.22 | | PAT Margin (%) | 11.41% | 14.46% | 14.35% | | Total Assets | 52.69 | 66.04 | 97.04 | | Net Worth | 17.60 | 25.86 | 48.24 | | Return on Net Worth (RoNW %) | 29.09% | 31.94% | 21.18% | +-------------------------------+-------------------+-------------------+-----------+
(Source: Restated Financial Statements in Prospectus & KPI Reports)
Key Financial Observations:
- Consistent Revenue Growth: Revenue from operations expanded from ₹44.87 crore in FY24 to ₹57.11 crore in FY25, before jumping to ₹71.22 crore in FY26 (total income reaching ₹72.93 crore, a 2-year growth of 58.7%).
- Expanding Operating EBITDA (25.16%): Operating EBITDA grew from ₹8.12 crore in FY24 to ₹17.92 crore in FY26, with EBITDA margins expanding to 25.16% due to improved product mix and in-house processing efficiencies.
- Strong Profit Growth: Net profit after tax (PAT) rose from ₹5.12 crore in FY24 to ₹8.26 crore in FY25, and reached ₹10.22 crore in FY26 (delivering a 14.35% PAT margin).
- Solid Balance Sheet Net Worth: Consolidated Net Worth expanded to ₹48.24 crore in FY26 (further rising to ₹50.74 crore in the 2-month period ended May 31, 2026), supporting an RoNW of 21.18%.
5. Structure of the Offer & Objects of the Issue
The ₹47.24 crore public issue is structured entirely as a fresh primary capital issuance:
+-----------------------------------------------------------------------------------+ | IPO CAPITAL STRUCTURE BREAKDOWN | +-----------------------------------+-----------------------------------------------+ | Total Issue Size | ₹47.24 Crore (56,91,200 Equity Shares) | +-----------------------------------+-----------------------------------------------+ | Fresh Issue Component | ₹47.24 Crore (100% Fresh Capital Issue) | +-----------------------------------+-----------------------------------------------+ | Offer for Sale (OFS) Component | ₹0.00 (No Selling Shareholders) | +-----------------------------------+-----------------------------------------------+ | Price Band | ₹79.00 to ₹83.00 per share | +-----------------------------------+-----------------------------------------------+ | Face Value | ₹10 per share | +-----------------------------------+-----------------------------------------------+ | Market Maker Reserved Block | 2,84,800 Shares (₹2.36 Crore Value) | +-----------------------------------+-----------------------------------------------+ | Anchor Allocation | 16,19,200 Shares (₹13.44 Crore Value) | +-----------------------------------+-----------------------------------------------+ | Net Offer to Public | 37,87,200 Shares (₹31.43 Crore Value) | +-----------------------------------+-----------------------------------------------+ | Lead Manager (BRLM) | Vivro Financial Services Private Limited | +-----------------------------------+-----------------------------------------------+ | Registrar to the Issue | KFin Technologies Limited | +-----------------------------------+-----------------------------------------------+
How Will Fresh Primary Capital Be Deployed?
Because there is no Offer for Sale (OFS), 100% of the proceeds move directly onto the company balance sheet:
- Funding Capital Expenditure for Manufacturing Expansion: Setting up additional processing units and procuring specialized storage vessels for sulfur derivatives.
- Working Capital Requirements: Procuring bulk elemental sulfur and industrial chemical raw materials while managing customer receivables.
- General Corporate Purposes & Issue Expenses: Supporting operational infrastructure and issue processing costs.
6. Valuation Analysis & Peer Group Comparison
At the upper price band cap of ₹83 per share, Shanti Inorganics is priced at a trailing Price-to-Earnings (P/E) multiple of 9.39x based on pre-issue basic EPS of ₹8.84 (and 9.54x based on post-issue diluted capital of 1,72,47,400 shares with diluted FY26 EPS of ₹8.70), establishing a post-issue corporate market capitalization of approximately ₹143.15 crore.
Let's compare this with listed specialty chemical, catalyst, and inorganic chemical peers in India:
+-----------------------------------------------------------------------------------+ | PEER GROUP VALUATION COMPARISON | +-----------------------------------+--------------------+--------------------------+ | Company Name | Trailing P/E (x) | Primary Focus / Model | +-----------------------------------+--------------------+--------------------------+ | Shanti Inorganics (At ₹83) | ~9.54x (Post-IPO) | Sulfur Inorganic Chems | | Devson Catalyst Ltd | ~18.50x | Catalysts & Inorganics | | Vahh Chemicals Ltd | ~21.20x | Specialty Chemical Interm| | Biopol Chemicals Ltd | ~24.80x | Polymer & Industrial Chem| | Chemcon Speciality Chemicals | ~28.40x | Pharma & Oilfield Chems | +-----------------------------------+--------------------+--------------------------+
Valuation Summary:
At ~9.5x post-issue FY26 trailing earnings, Shanti Inorganics enters the market at an attractive entry valuation compared to listed chemical and intermediate manufacturers (18x–28x P/E).
With revenue at ₹71.22 crore, PAT exceeding ₹10.22 crore, a 25.16% EBITDA margin, and 100% fresh issue deployment into capacity expansion, the ~9.5x multiple leaves a strong fundamental margin of safety that catalyzed the 142.16x final oversubscription and strong grey market premium (+₹32–₹38).
7. Core Strengths vs. Key Business Risks
Investors evaluating this SME chemical manufacturing issue should consider the following operational factors:
Key Strengths:
- Blockbuster Final Subscription (142.16x): Total primary demand breached ₹4,468 crore with HNIs at 195.53x, QIBs at 130.97x, and retail at 125.70x.
- 100% Fresh Issue Structure: No promoter cash-out; capital deployed directly into capacity expansion and working capital.
- Disciplined Valuation (9.54x Post-IPO P/E): Priced attractively relative to listed specialty chemical peers.
- Strong Operating Margins: Delivering a 25.16% EBITDA margin and 14.35% PAT margin in FY26.
Key Risk Factors:
- Raw Material Price Volatility: Elemental sulfur prices fluctuate in line with global crude oil refining and petrochemical cycles.
- Strict Environmental Regulations: Chemical processing is subject to hazardous substance storage, environmental emissions, and safety guidelines.
- High Retail Application Threshold: The minimum investment required for retail applicants was ₹2,65,600 (2 lots / 3,200 shares), which restricts participation from smaller retail accounts.
8. Application Matrix & Final Listing Timeline
With the public offer now closed, here is the upcoming schedule for allotment finalization and listing:
- Public Bidding Window Closes: Wednesday, September 2, 2026 (Status: Bidding Closed)
- Basis of Allotment Finalization: Thursday, September 3, 2026
- Refund Initiations & Unblocking of Bank Funds: Friday, September 4, 2026
- Credit of Equity Shares to Demat Accounts: Friday, September 4, 2026
- Official Stock Exchange Listing (NSE SME): Monday, September 7, 2026
- Designated Lead Manager: Vivro Financial Services Private Limited
- Designated Registrar: KFin Technologies Limited
How to Check Your Allotment Status:
When allotment details go live on Thursday, September 3, 2026, applicants can check their status by entering their PAN card number or Application ID on the KFin Technologies Portal or directly on the official NSE website under the SME allotment section.
Conclusion
Shanti Inorganics has concluded its public offering with a massive 142.16x overall subscription (~₹4,468.63 crore total primary demand), propelled by 195.53x HNI bidding, 130.97x QIB demand, and 125.70x retail coverage.
With ₹71+ crore in revenue scale, ₹10.22 crore reported PAT, 25.16% EBITDA margins, 100% fresh primary proceeds funding plant capex, and an attractive 9.54x post-issue trailing P/E entry valuation, the company is set for its SME debut on the NSE Emerge platform on Monday, September 7.
Post Excerpt
A complete final day analysis of the ₹47.24 crore Shanti Inorganics SME IPO. Total subscription closed at an explosive 142.16x, led by 195.53x in HNIs, 130.97x in QIBs, and 125.70x in retail as total primary demand crossed ₹4,468 crore. Read our full review of company financials (₹71+ Cr revenue, ₹10.22 Cr PAT, 25.2% EBITDA margin), sulfur chemical moats, grey market trends (+₹32–₹38), allotment schedule, and valuation (9.54x post-issue P/E) ahead of its September 7 listing.
